Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04449679 · ClinicalTrials.gov registry record · NA
Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study
A NA study of Clinical Stage II Esophageal Adenocarcinoma AJCC v8 and Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
- 1
- Study location
NCT04449679 is a NA study of Clinical Stage II Esophageal Adenocarcinoma AJCC v8 and Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8 that has completed, run by Thomas Jefferson University. The registered enrollment target is 34 participants, below the 86-participant average among 10 other Clinical Stage II Esophageal Adenocarcinoma AJCC v8 trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04449679, a NA study of Clinical Stage II Esophageal Adenocarcinoma AJCC v8 and Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial tests new methods and materials for the real-time chemotherapy-associated side effects monitoring support system (RT-CAMSS) in patients with gastrointestinal cancers undergoing chemotherapy. RT-CAMSS is a monitoring support system that provides patients with evidence-based information and side-effect management and coping skills, emotional support and validation, and proactive care via text messages and questionnaires as they undergo chemotherapy.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Consultation
- OTHER Patient Monitoring System
Study Locations (1)
Pennsylvania
- Thomas Jefferson University Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2020-04-15 |
| Est. Completion | 2022-02-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04449679
The ClinicalTrials.gov registry entry for NCT04449679 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 10 other Clinical Stage II Esophageal Adenocarcinoma AJCC v8 trials with a reported enrollment target (60% lower). The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Clinical Stage II Esophageal Adenocarcinoma AJCC v8 appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT04449679 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04449679 about?
NCT04449679 is a clinical study titled "Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study". This trial tests new methods and materials for the real-time chemotherapy-associated side effects monitoring support system (RT-CAMSS) in patients with gastrointestinal cancers undergoing chemotherapy. RT-CAMSS is a monitoring support system that provides patients with evidence-based information and...
What is the current status of trial NCT04449679?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2020-04-15. Estimated completion is 2022-02-24.
What conditions does trial NCT04449679 study?
This clinical trial studies the following conditions: Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage I Gastric Cancer AJCC v8.
What interventions are being tested in trial NCT04449679?
The interventions under investigation include: Questionnaire Administration (OTHER), Consultation (OTHER), Patient Monitoring System (OTHER).
Who is sponsoring clinical trial NCT04449679?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04449679 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Clinical Stage II Esophageal Adenocarcinoma AJCC v8
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer
RECRUITING · NA
-
Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma
RECRUITING · Phase 2
-
Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma
RECRUITING · Phase 2
-
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
RECRUITING · Phase 2
-
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
RECRUITING · Phase 3
-
NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer
RECRUITING · Phase 1
Explore more on PlainTrial
Clinical Stage II Esophageal Adenocarcinoma AJCC v8
All registered trials for this condition
Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8
All registered trials for this condition
Pennsylvania
All trials with a study site in Pennsylvania
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.